Heightened mRNA expression levels of mEAK-7 have been observed in several cancer cell lines (5) and there is significant elevation of both mEAK-7 and mTOR signaling in tumor and metastatic lymph nodes of patients diagnosed with NSCLC (14). This evidence concerns the gene MEAK7 and non-small cell lung carcinoma.